September 11, 2023 Comments Off on New patent for Taiho Oncology drug LONSURF Posted in: Patent Added Annual Drug Patent Expirations for LONSURF Lonsurf is a drug marketed by Taiho Oncology and is included in one NDA. It is available from one supplier. There are six patents…
The post New patent for Taiho Oncology drug LONSURF appeared first on DrugPate…
September 11, 2023 Comments Off on New patent expiration for Novartis drug TYZEKA Posted in: Uncategorized
Annual Drug Patent Expirations for TYZEKA Tyzeka is a drug marketed by Novartis and is included in two NDAs. There are two patents protecting this drug. This drug has eleven…
The post New patent expiration for Novartis drug TYZEKA appeared first on Dru…
